CA3290135A1 - Lipides destinés à être utilisés dans des formulations de nanoparticules lipidiques - Google Patents

Lipides destinés à être utilisés dans des formulations de nanoparticules lipidiques

Info

Publication number
CA3290135A1
CA3290135A1 CA3290135A CA3290135A CA3290135A1 CA 3290135 A1 CA3290135 A1 CA 3290135A1 CA 3290135 A CA3290135 A CA 3290135A CA 3290135 A CA3290135 A CA 3290135A CA 3290135 A1 CA3290135 A1 CA 3290135A1
Authority
CA
Canada
Prior art keywords
lipids
lipid nanoparticle
nanoparticle formulations
formulations
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3290135A
Other languages
English (en)
Inventor
Jason Samuel Tan
Stephen Paul ARNS
Julia Gatenyo
Original Assignee
Acuitas Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acuitas Therapeutics Inc filed Critical Acuitas Therapeutics Inc
Publication of CA3290135A1 publication Critical patent/CA3290135A1/fr
Pending legal-status Critical Current

Links

CA3290135A 2023-05-05 2024-05-03 Lipides destinés à être utilisés dans des formulations de nanoparticules lipidiques Pending CA3290135A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/500,511 2023-05-05

Publications (1)

Publication Number Publication Date
CA3290135A1 true CA3290135A1 (fr) 2024-11-14

Family

ID=

Similar Documents

Publication Publication Date Title
AU2024267189A1 (en) Lipids for use in lipid nanoparticle formulations
IL313486A (en) Lipids for use in lipid nanoparticle formulations
IL319190A (en) Lipids for use in lipid nanoparticle formulations
AU2024303057A1 (en) Lipids for use in lipid nanoparticles
EP4262883A4 (fr) Lipides peg et nanoparticules lipidiques
IL320873A (en) Novel polyglycerol-conjugated lipids and lipid nanoparticle compositions containing them
AU2024360942A1 (en) Glutamic acid-based lipids, lipid nanoparticle containing glutamic acid-based lipids, and formulations thereof
AU2024361533A1 (en) Ionizable lipids for use in lipid nanoparticles
HK40129586A (en) Lipids for use in lipid nanoparticle formulations
HK40117582A (en) Lipids for use in lipid nanoparticle formulations
CA3294473A1 (fr) Lipides destinés à être utilisés dans des nanoparticules lipidiques
CA3308154A1 (fr) Lipides ionisables destinés à être utilisés dans des nanoparticules lipidiques
CA3296602A1 (fr) Analogues de stérol dans des formulations de nanoparticules lipidiques
AU2025903067A0 (en) Lipid Nanoparticle Formulations
CA3283233A1 (fr) Nouveaux lipides structuraux pour formulation de nanoparticules lipidiques
AU2024226024A1 (en) Novel structural lipids for lipid nanoparticle formulation
HK40093054A (en) Cationic lipids for use in lipid nanoparticles
CA3297922A1 (fr) Lipides diester, nanoparticule lipidique contenant des lipides diester et formulations associées
AU2021902567A0 (en) Lipid nanoparticle formulations
HK40117584A (zh) 用於脂质纳米颗粒的氟代阳离子脂质
HK40117583A (en) Fluorinated cationic lipids for use in lipid nanoparticles
IL325527A (en) Sterol analogs in lipid nanoparticle formulations
CA3296444A1 (fr) Nanoparticules lipidiques contenant des lipides disulfure et formulations associées
IL325839A (en) Diester lipids, lipid nanoparticle containing diester lipids, and formulations thereof
HK40100097A (en) Stable liquid lipid nanoparticle formulations